Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
01/2009
01/01/2009US20090004237 B7-Like Molecules and Uses Thereof
01/01/2009US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same
01/01/2009US20090004199 Antibodies that bind both il-17a and il-17f and methods of using the same
01/01/2009US20090004183 Compositions and Methods for Regulating the Alternative Pathway of Complement
01/01/2009US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE
12/2008
12/31/2008WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists
12/31/2008WO2009001915A1 Substituted imidazole compound and use thereof
12/31/2008WO2009001555A1 Expression controller of type i interferon
12/31/2008WO2009001551A1 Regulator of activity of bone-forming protein
12/31/2008WO2009000877A1 Cysteine protease inhibitors
12/31/2008WO2009000832A2 Chemical compounds
12/31/2008WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
12/31/2008WO2009000132A1 Immediate release effervescent-formulation and preparing process thereof
12/31/2008WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
12/31/2008WO2009000038A1 Combination methods and compositions for treatment of neuropathic pain
12/31/2008WO2008140066A3 Pyridone derivatives as p38a mapk inhibitors
12/31/2008WO2008132568A3 Fusion proteins binding to growth factors
12/31/2008WO2008109493B1 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
12/31/2008WO2008109493A4 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
12/31/2008WO2008082487A3 Novel jnk inhibitors
12/31/2008WO2008057859A3 Modulators of glucocorticoid receptor, ap-i and/or nf-kappab activity and use thereof
12/31/2008WO2008023278A8 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain
12/31/2008WO2008003978A3 Dioxo-alkanes and dioxo-alkenes
12/31/2008EP2009018A2 T cell antigen receptor peptides
12/31/2008EP2009006A1 Ureide derivative and use thereof for medical purposes
12/31/2008EP2008655A1 Pharmaceutical composition that comprises an analgesic and vitamins
12/31/2008EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides
12/31/2008EP2008650A2 Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol
12/31/2008EP2008649A1 Spill resistant pharmaceutical compositions
12/31/2008EP2007815A2 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors
12/31/2008EP2007790A1 Compounds and methods for the treatment of pain
12/31/2008EP2007772A1 Thiazolyl-dihydroquinazolines
12/31/2008EP2007735A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
12/31/2008EP2007707A1 Compounds which modulate the cb2 receptor
12/31/2008EP2007702A2 Conjugated lipid derivatives
12/31/2008EP2007401A2 Anti-inflammatory polymer
12/31/2008EP1838283B1 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
12/31/2008EP1558230B1 Spirocyclopropyl amides and acids and their therapeutic applications
12/31/2008EP1543013B1 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]amino]thiazolo[4,5-d]pyrimidin-2(3H)-one monosodium salt as CXCR2 antagonist
12/31/2008EP1542974B1 5-[((2,3-difluorophenyl)methyl)thio]-7-{[(1S,2S)-2-hydroxy-1-(hydroxymethyl)propyl]amino}thiazolo[4,5-d]pyrimidin-2(3H)-one as CXCR2 antagonist
12/31/2008EP1507775B1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
12/31/2008EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
12/31/2008EP1412503B1 A fusion protein
12/31/2008EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
12/31/2008EP1406867B1 Thiolalkyl benzoic acid derivatives
12/31/2008EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
12/31/2008EP1309587B1 Cinnoline compounds
12/31/2008EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/31/2008EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis
12/31/2008EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids
12/31/2008EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents
12/31/2008CN101333187A Novel PI3K enzyme inhibitors and uses thereof
12/31/2008CN101333166A New depside compounds, preparation method thereof and use
12/31/2008CN101332292A Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
12/31/2008CN101332291A Medicine for treating intractable rheumatoid arthritis
12/31/2008CN101332282A Traditional Chinese medicine composition for treating gynecologic diseases reduced by kidney deficiency and genitals coldness
12/31/2008CN101332240A Medicine for treating and preventing postnatal disease
12/31/2008CN101332238A Traditional Chinese medicine for treating vascular headache
12/31/2008CN101332235A Magnolia bark and processing technique
12/31/2008CN101332219A Broken pollen extract and extracting method and use thereof
12/31/2008CN101332200A New use of tripchlorolide,T4
12/31/2008CN101332186A Medicine composition for injecting triamcinolone acetonide palmitate lipid microsphere and preparation method thereof
12/31/2008CN101332183A O/W emulsification preparation containing steride
12/31/2008CN101332177A Solid preparation containing ibuprofen, tranexamic acid and calcium silicate
12/31/2008CN101332036A Natural plant health preserving pillow
12/31/2008CN101331991A Sweat absorption and moisture protection traditional Chinese medicine kneecap for building, mine worker
12/31/2008CN100447244C BAFF receptor (BCMA), immunoregulatory agent
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100447141C Hetero-bicyclic crf antagonists
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446790C Traditional Chinese medicine injection for treating pig fever symptom and preparation thereof
12/31/2008CA2691888A1 New chemical compounds
12/31/2008CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
12/31/2008CA2690344A1 Cysteine protease inhibitors
12/30/2008US7470698 Adenosine A3 receptor modulators
12/30/2008US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
12/30/2008US7470687 Aryl oximes
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470681 Pyrimidine compounds
12/30/2008CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
12/30/2008CA2368767C Protease resistant flint analogs
12/30/2008CA2351703C Novel 4-dedimethylaminotetracycline derivatives
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
12/30/2008CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules
12/25/2008US20080319085 Titration dosing regimen for controlled release tramadol
12/25/2008US20080319083 Medicine for transnasal administration
12/25/2008US20080319051 Liquiritigenin and derivatives as selective estrogen receptor beta agonists
12/25/2008US20080319050 Preparation Containing Oxidized Flavonoid Derivatives
12/25/2008US20080319031 Novel Tyrosine Derivatives
12/25/2008US20080318991 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/25/2008US20080318977 Condensed Pyridines as Kinase Inhibitors
12/25/2008US20080318960 PAR2-modulating compounds and their use
12/25/2008US20080318935 Substituted imidazoheterocycles
12/25/2008US20080318932 Sodium Channel Blocker Compositions and the Use Thereof
12/25/2008US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta
12/25/2008US20080318899 Pyridazine Compounds, Compositions and Methods
12/25/2008US20080318885 Method for Modulating Responsiveness to Steroids
12/25/2008US20080318868 Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation
12/25/2008US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 1272